Clinical trial
Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors
NCT00016185 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00016185 |
|---|---|
| Title | Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study Of Flavopiridol And Docetaxel (Taxotere) In Patients With Advanced Cancers |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | alvocidib, docetaxel |
| Start date | Mar 1, 2001 |
| Primary completion | Feb 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: